LexDanaLexDanabeta
Inventor

Yong-Jin Wu

Inventor
Madison, CT, US

Overview

43→
Patents
2000–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 43 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%
A61KPreparations for medical, dental or toiletry purposes14%
C07HSugars14%
C07CAcyclic or carbocyclic compounds7%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
C07BGeneral methods of organic chemistry1%
PatentTitleYear
10,836,758Acyl sulfonamide NaV1.7 inhibitors202010,526,323Indazole and azaindazole substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction202010,227,343Isoquiniline and napthalene-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction201910,072,002Pyridinylaminopyrimidine derivatives, preparation process and use thereof20189,475,784'4,6-diarylaminothiazines as BACE1 inhibitors and their use for the reduction of beta-amyloid production'20168,710,061'Compounds for the reduction of β-amyloid production'20148,637,525'Compounds for the reduction of beta-amyloid production'20148,637,523'Compounds for the reduction of beta-amyloid production'20148,604,024'Compounds for the reduction of beta-amyloid production'20138,598,161'Compounds for the reduction of beta-amyloid production'20138,486,952'Compounds for the reduction of β-amyloid production'20138,349,880'Bicyclic compounds for the reduction of beta-amyloid production'20137,772,221'Diaminopropane derived macrocycles as inhibitors of β amyloid production'20107,678,784'Oxime-containing macrocyclic acyl guanidines as β-secretase inhibitors'20107,494,986'Cycloalkylamine derivatives as NK-1/SSRI antagonists'20097,476,764'Phenylcarboxyamides as beta-secretase inhibitors'20097,390,925'Oxime-containing acyl guanidines as beta-secretase inhibitors'20087,276,631'Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonists'20077,273,866'2-aryl thiazole derivatives as KCNQ modulators'20077,144,881'Arylcyclopropylcarboxylic amides as potassium channel openers'20067,138,423'Arylpyrrolidine derivatives as NK-1 /SSRI antagonists'20067,135,472'3-Heterocyclic benzylamide derivatives as potassium channel openers'20067,098,203'Homopiperidine derivatives as NK-1 antagonists'20067,087,609'3-(pyridinyl-piperazin-1-yl)-phenylethyl amides as potassium channel openers'20067,045,551'1-aryl-2-hydroxyethyl amides as potassium channel openers'20066,933,308'Aminoalkyl thiazole derivatives as KCNQ modulators'20056,900,210'Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers'20056,875,771'Pyridopyrimidine derivatives as 5-HT6 antagonists'20056,831,080'Cinnamide derivatives as KCNQ potassium channel modulators'20046,825,171'Erythromycin derivatives'20046,800,590'2-Pyrimidinyloxy-n-aryl-benzylamine derivatives,their processes and uses'20046,777,543'13-methyl erythromycin derivatives'20046,664,238'Carbamate and carbazate ketolide antibiotics'20036,498,146'Erythromycin derivatives'20026,482,801'9a, 11b-dehydro derivatives of 9-oxime-3-keto-6-O- methylerythromycin'20026,420,343'Carbamate and carbazate ketolide antibiotics'20026,300,316'C-4 substituted macrolide antibiotics'20016,291,656'Tricyclic erythromycin derivatives'20016,262,030'Erythromycin derivatives'20016,258,785'Crystalline 9-E-(O-methyl)oxime of 11, 12-dideoxy-3-de(2,6-dideoxy-3-C-methyl-3-O-methyl-.alpha.-L-ribohexopyrano syloxy)-6-O-methyl-12,11-(iminocarbonyl-(2-(3-(4-(3-pyridinyl)1H-imadazol-1 -yl)propyl)hydrazono))-3-oxoerythromycin'20016,248,719'Tricyclic 3-keto derivatives of 6-O-methylerthromycin'20016,162,794'Erythromycin derivatives'20006,159,945'9-amino-3-keto erythromycin derivatives'2000

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2000–2004Patents assigned to PFIZER (13)· patent assignee history
2000–2002Based in East Lyme, CT, US· patent location history
2001–2020Based in Madison, CT, US· patent location history
2004–2020Patents assigned to BRISTOL MYERS SQUIBB CO (25)· patent assignee history
2004–2018Based in Shanghai, CN· patent location history
2013–2014Patents assigned to WU YONG-JIN (7)· patent assignee history
2013–2014Patents assigned to THOMPSON III LORIN A (6)· patent assignee history
2013–2014Patents assigned to BOY KENNETH M (5)· patent assignee history
2019–2020Based in Princeton, NJ, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
BRISTOL MYERS SQUIBB CO252004–2020
PFIZER132000–2004
WU YONG-JINself72013–2014
THOMPSON III LORIN A62013–2014
BOY KENNETH M52013–2014
Locations
LocationPatentsSpan
Madison, CT, US312001–2020
East Lyme, CT, US82000–2002
Princeton, New Jersey, US22019–2020
Shanghai, CN22004–2018